gene expression profiling predicts clinical outcome breast cancer 
breast cancer patients stage disease can markedly different treatment responses overall outcome strongest predictors metastases example lymph node status histological grade fail classify accurately breast tumours according clinical behaviour- chemotherapy hormonal therapy reduces risk distant metastases approximately one-third however % patients receiving treatment survived without none signatures breast cancer gene expression reported date- allow patient-tailored therapy strategies used dna microarray analysis supervised classification identify gene expression signature strongly predictive short interval distant metastases poor prognosis signature patients without tumour cells local lymph nodes diagnosis lymph node negative addition established signature identifies tumours brca1 carriers poor prognosis signature consists genes regulating cell cycle invasion metastasis angiogenesis gene expression profile will outperform currently used clinical parameters predicting disease outcome findings provide strategy select patients benefit adjuvant therapy 
